Literature DB >> 9191054

Differentiation dependent expression and distinct subcellular localization of the protooncogene product, PEBP2beta/CBFbeta, in muscle development.

N Chiba1, T Watanabe, S Nomura, Y Tanaka, M Minowa, M Niki, R Kanamaru, M Satake.   

Abstract

The Pebpb2/Cbfb gene encodes the non-DNA binding subunit of the heterodimeric transcription factor, PEBP2/CBF. To examine the expression of the PEBP2beta/CBFbeta protein in vivo, we carried out immunohistochemistry using the tissues from adult mice as well as embryos. Although PEBP2beta/CBFbeta was detected in various tissues to various degrees, interesting features of expression were observed in the skeletal myogenic cells. Here PEBP2beta/CBFbeta was found mainly to occur as cytoplasmic staining and the intensity of this staining increased depending on the differentiation stage of the cells. In the undifferentiated myoblasts PEBP2beta/CBFbeta was undetectable, whereas moderate levels of PEBP2beta/ CBFbeta were detected in the elongated and aligned myocytes. PEBP2beta/CBFbeta appeared to accumulate further when the cells fused to each other to become multinucleated myotubes. Once the muscle fibers were established, PEBP2beta/CBFbeta was relocated onto or around the Z-lines. PEBP2beta/CBFbeta was also detected in the cytoplasm of cardiac myocytes and in the smooth muscle cells of the digestive tract. In all the above, the skeletal myotubes were the only case that showed both nuclear and cytoplasmic staining of PEBP2beta/CBFbeta. Thus, we could show differentiation dependent pattern of PEBP2beta/CBFbeta expression in muscle development and establish PEBP2beta/CBFbeta to be a cytoplasmic as well as nuclear protein in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191054     DOI: 10.1038/sj.onc.1201109

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  SMAP2, a novel ARF GTPase-activating protein, interacts with clathrin and clathrin assembly protein and functions on the AP-1-positive early endosome/trans-Golgi network.

Authors:  Waka Natsume; Kenji Tanabe; Shunsuke Kon; Naomi Yoshida; Toshio Watanabe; Tetsuo Torii; Masanobu Satake
Journal:  Mol Biol Cell       Date:  2006-03-29       Impact factor: 4.138

2.  Over-expression of Runx1 transcription factor impairs the development of thymocytes from the double-negative to double-positive stages.

Authors:  Won F Wong; Megumi Nakazato; Toshio Watanabe; Kazuyoshi Kohu; Takehiro Ogata; Naomi Yoshida; Yusuke Sotomaru; Mamoru Ito; Kimi Araki; Janice Telfer; Manabu Fukumoto; Daisuke Suzuki; Takehito Sato; Katsuto Hozumi; Sonoko Habu; Masanobu Satake
Journal:  Immunology       Date:  2010-01-19       Impact factor: 7.397

3.  ASB2α, an E3 ubiquitin ligase specificity subunit, regulates cell spreading and triggers proteasomal degradation of filamins by targeting the filamin calponin homology 1 domain.

Authors:  Ziba Razinia; Massimiliano Baldassarre; Gaia Cantelli; David A Calderwood
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

4.  A novel GTPase-activating protein for ARF6 directly interacts with clathrin and regulates clathrin-dependent endocytosis.

Authors:  Kenji Tanabe; Tetsuo Torii; Waka Natsume; Sten Braesch-Andersen; Toshio Watanabe; Masanobu Satake
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

5.  Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor.

Authors:  Naomi Yoshida; Takehiro Ogata; Kenji Tanabe; Songhua Li; Megumi Nakazato; Kazuyoshi Kohu; Toshiro Takafuta; Sandor Shapiro; Yasutaka Ohta; Masanobu Satake; Toshio Watanabe
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 6.  Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle.

Authors:  Nelsa L Estrella; Francisco J Naya
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

7.  The core binding factor CBF negatively regulates skeletal muscle terminal differentiation.

Authors:  Ophélie Philipot; Véronique Joliot; Ouardia Ait-Mohamed; Céline Pellentz; Philippe Robin; Lauriane Fritsch; Slimane Ait-Si-Ali
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

8.  A variant of Runx2 that differs from the bone isoform in its splicing is expressed in spermatogenic cells.

Authors:  Satoru Kanto; Marcin Grynberg; Yoshiyuki Kaneko; Jun Fujita; Masanobu Satake
Journal:  PeerJ       Date:  2016-04-04       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.